Authors:
SJOSTROM J
KRAJEWSKI S
FRANSSILA K
NISKANEN E
WASENIUS VM
NORDLING S
REED JC
BLOMQVIST C
Citation: J. Sjostrom et al., A MULTIVARIATE-ANALYSIS OF TUMOR BIOLOGICAL FACTORS PREDICTING RESPONSE TO CYTOTOXIC TREATMENT IN ADVANCED BREAST-CANCER, British Journal of Cancer, 78(6), 1998, pp. 812-815
Authors:
SJOSTROM J
KRAJEWSKI S
FRANSSILA K
NISKANEN E
WASENIUS VM
NORDLING S
REED JC
BLOMQVIST C
Citation: J. Sjostrom et al., A MULTIVARIATE-ANALYSIS OF TUMOR BIOLOGIC FACTORS PREDICTING RESPONSETO CYTOTOXIC TREATMENT IN ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 882-882
Authors:
NISKANEN E
BLOMQVIST C
FRANSSILA K
HIETANEN P
WASENIUS VM
Citation: E. Niskanen et al., PREDICTIVE VALUE OF C-ERBB-2, P53, CATHEPSIN-D AND HISTOLOGY OF THE PRIMARY TUMOR IN METASTATIC BREAST-CANCER, British Journal of Cancer, 76(7), 1997, pp. 917-922
Authors:
KRAJEWSKI S
BLOMQVIST C
FRANSSILA K
KRAJEWSKA M
WASENIUS VM
NISKANEN E
NORDLING S
REED JC
Citation: S. Krajewski et al., REDUCED EXPRESSION OF PROAPOPTOTIC GENE BAX IS ASSOCIATED WITH POOR RESPONSE RATES TO COMBINATION CHEMOTHERAPY AND SHORTER SURVIVAL IN WOMEN WITH METASTATIC BREAST ADENOCARCINOMA, Cancer research, 55(19), 1995, pp. 4471-4478
Authors:
HIETANEN P
BLOMQVIST C
WASENIUS VM
NISKANEN E
FRANSSILA K
NORDLING S
Citation: P. Hietanen et al., DO DNA-PLOIDY AND S-PHASE FRACTION IN PRIMARY TUMOR PREDICT THE RESPONSE TO CHEMOTHERAPY IN METASTATIC BREAST-CANCER, British Journal of Cancer, 71(5), 1995, pp. 1029-1032
Citation: Ge. Mumy et E. Niskanen, THE IMPACT OF DISTRIBUTIONAL OBJECTIVES ON THE TOLL AND CAPACITY OF ACONGESTIBLE FACILITY, Journal of urban economics, 34(3), 1993, pp. 401-413